LONG ISLAND CITY, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NEW YORK BIOTECHNOLOGY ASSOCIATION INC, founded in 1990, is a community nonprofit in the Community Improvement sector that reported $1.7M in total revenue in fiscal year 2025. Revenue surged 23% from the prior year, signaling strong growth momentum. Expenses of $1.5M left a modest 10% surplus.
TO PROMOTE & REPRESENT THE BIOTECHOLOGY INDUSTRY
PUBLICATION OF NEWSLETTERS AND INFORMATIONAL BROCHURES: TO ENCOURAGE DEVELOPMENT OF NEW LIFE SCIENCE COMPANIES, TO PROMOTE COOPERATIVE RELATIONS BETWEEN EXISTING COMPANIES, AND TO EDUCATE THE...
PUBLICATION OF NEWSLETTERS AND INFORMATIONAL BROCHURES: TO ENCOURAGE DEVELOPMENT OF NEW LIFE SCIENCE COMPANIES, TO PROMOTE COOPERATIVE RELATIONS BETWEEN EXISTING COMPANIES, AND TO EDUCATE THE COMMUNITY OF THE ROLE OF THE LIFE SCIENCES, SPONSORSHIP OF MEETINGS AND SEMINARS: TO PROVIDE A FORUM FOR AN EXCHANGE OF IDEAS, TO FOSTER COLLABORATIVE RESEARCH, TO ENHANCE RELATIONS WITH GOVT AGENCIES AND THE MEDICAL,SCIENTIFIC, EDUCATIONAL AND PROFESSIONAL COMMUNITY WITHIN NYS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $1,698,382 | $1,383,023 | +0.2% |
| Expenses | $1,530,876 | $1,301,887 | +0.2% |
| Net Income | $167,506 | $81,136 | +1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JENNIFER A HAWKS BLAND | CEO | 40.00 |
Officer
|
$321,300 | $0 | $321,300 |
| RANA AL-HALLAQ | VICE CHAIR | N/A |
Director
|
$0 | $0 | $0 |
| HANS CHRISTINGER | CHAIR | N/A |
Director
|
$0 | $0 | $0 |
| ANTHONY JOHNSON | SECRETARY | N/A |
Director
|
$0 | $0 | $0 |
| BOB VAN NOSTRAND | TREASURER | N/A |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,698,382 | $1,530,876 | $1,460,770 | $167,506 |
| 2024 | $1,383,023 | $1,301,887 | $1,311,295 | $81,136 |
| 2023 | $1,372,461 | $1,104,989 | $1,190,856 | $267,472 |
| 2022 | $1,043,331 | $920,485 | $944,644 | $122,846 |
| 2021 | $910,681 | $777,498 | $778,665 | $133,183 |
| 2020 | $862,407 | $818,995 | $583,396 | $43,412 |
| 2019 | $1,224,465 | $891,621 | $605,014 | $332,844 |
| 2018 | $977,427 | $1,033,473 | $296,478 | $-56,046 |
Compare NEW YORK BIOTECHNOLOGY ASSOCIATION INC with other nonprofits in New York and across the country.